橋本 健一

・In charge of Dx formulation support for next-generation pharmaceutical factories. Supporting the formulation of large-scale digital reform strategies in the production area from R&D by utilizing digital technology. Taking initiative in consideration of next-generation business operation model, technology selection, and negotiations with

・Participated as a start-up member of the automated manufacturing plant for the next major product, the highly active drug substance. Experienced from examination of production conditions to inspection response.